TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05807061

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EmBARK
Description: The narrated training teaches parents about children's biases and introduces multiple strategies for addressing children's biases. Families receive children's books to help practice the strategies.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Popular guidance
Description: The popular press articles teach parents about children's biases and guide parents about how to talk to children about race. Families receive children's books focused on race to help practice talking about race.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Practice first
Description: Animal books are provided to parents to help them practice talking to their children when reading books. Then, families receive a training program about race as well as children's books about race.
Study: NCT04865328

Intervention type: OTHER
Intervention: Overactive Bladder-Validated 8-question Screener (OAB-V8)
Description: OAB-V8 is an eight-item, self-reported questionnaire that assesses the burden of OAB and the degree of bother caused by the symptoms. Since its development as a subscale of the overactive bladder questionnaire (OAB-q), the OAB-V8 questionnaire has been used to screen for OAB and to assess OAB symptom burden and severity.
Study: NCT05637918

Intervention type: OTHER
Intervention: Group 1 (Patients who recorded as Grade 0)
Description: When the gastric contents were evaluated with the upper gastrointestinal endoscopy, the stomach was completely empty in Group 1 that patients who recorded as Grade 0.

Intervention type: OTHER
Intervention: Group 2 ( Patients who recorded as Grade 1)
Description: When the gastric contents were evaluated with the endoscope, small volume of gastric clear fluid was visible and gastric content aspirated and measured in Group 2 that patients who recorded as Grade 1.
Study: NCT04897464

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BGaze therapy Alzheimer
Description: BGaze Therapy is an interactive eye tracking game
Study: NCT05789030

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diprospan plus iguratimod
Description: Patients are treated with Diprospan (1mL im) and then with iguratimod (25mg bid) for 12 months.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diprospan plus leflunomide
Description: Patients are treated with Diprospan (1mL im) and then with leflunomide (10-20mg qd) for 12 months.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone plus leflunomide
Description: Patients are treated with prednisone (20 mg qd and taper to ≦ 5mg in 3 months) and leflunomide (10-20mg qd) for 12 months.
Study: NCT05962567

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non surgical periodontal therapy
Description: scaling and subgingival debridement
Study: NCT05946356

Intervention type: OTHER
Intervention: no intervention - cross-sectional observational only
Description: no intervention - cross-sectional observational only
Study: NCT03593252

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Senna
Description: Laxative,used for bowel preparation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Picosulfate, Magnesium Oxide and Citric Acid
Description: Laxative used for bowel preparation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole Oral
Description: Oral antibiotic

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metronidazole Oral
Description: Oral antibiotic

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neomycin
Description: Oral non-absorbable antibiotic

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neomycin
Description: Oral non-absorbable antibiotic

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cefazolin
Description: Intravenous antibiotic to be given on anesthesia induction and prior to incision as a prophylactic antibiotic.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cefazolin
Description: Intravenous antibiotic to be given on anesthesia induction and prior to incision as a prophylactic antibiotic.
Study: NCT05407662

Intervention type: OTHER
Intervention: sMRA therapies
Description: No drug will be provided to participants. Patients follow routine clinical practice/administration.
Study: NCT05861349

Intervention type: DIAGNOSTIC_TEST
Intervention: Nerve conduction study
Description: Nerve conduction study of median and ulnar nerve together with sensory comparative methods on the affected side (sides).

Intervention type: DIAGNOSTIC_TEST
Intervention: Nerve conduction study
Description: Nerve conduction study of median and ulnar nerve together with sensory comparative methods on the affected side (sides).

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: Ultrasound of the median nerve on the affected side (sides).

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: Ultrasound of the median nerve on the affected side (sides).
Study: NCT05680441

Intervention type: OTHER
Intervention: Peirodontal clinical measurements and gingival crevicular fluid sampling
Description: The clinical periodontal examination of the healthy and periodontitis subjects consisted of plaque index (PI), probing pocket depth (PPD), clinical attachment level (CAL), and bleeding on probing (BOP) recorded. CAL was calculated by adding GR to the PPD values. Averages for full mouth PPD, CAL, and the percentage of sites with BOP were calculated for each subject. A single calibrated examiner (VO) conducted a full mouth periodontal examination of all participants.

Intervention type: OTHER
Intervention: Peirodontal clinical measurements and gingival crevicular fluid sampling
Description: The clinical periodontal examination of the healthy and periodontitis subjects consisted of plaque index (PI), probing pocket depth (PPD), clinical attachment level (CAL), and bleeding on probing (BOP) recorded. CAL was calculated by adding GR to the PPD values. Averages for full mouth PPD, CAL, and the percentage of sites with BOP were calculated for each subject. A single calibrated examiner (VO) conducted a full mouth periodontal examination of all participants.

Intervention type: OTHER
Intervention: Peirodontal clinical measurements and gingival crevicular fluid sampling
Description: The clinical periodontal examination of the healthy and periodontitis subjects consisted of plaque index (PI), probing pocket depth (PPD), clinical attachment level (CAL), and bleeding on probing (BOP) recorded. CAL was calculated by adding GR to the PPD values. Averages for full mouth PPD, CAL, and the percentage of sites with BOP were calculated for each subject. A single calibrated examiner (VO) conducted a full mouth periodontal examination of all participants.

Intervention type: OTHER
Intervention: Peirodontal clinical measurements and gingival crevicular fluid sampling
Description: The clinical periodontal examination of the healthy and periodontitis subjects consisted of plaque index (PI), probing pocket depth (PPD), clinical attachment level (CAL), and bleeding on probing (BOP) recorded. CAL was calculated by adding GR to the PPD values. Averages for full mouth PPD, CAL, and the percentage of sites with BOP were calculated for each subject. A single calibrated examiner (VO) conducted a full mouth periodontal examination of all participants.
Study: NCT05854498

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal irinotecan
Description: 50mg/m2 IV on days 1 and 15

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAS102
Description: 35mg/m2 PO BID on days 1-5 and 15-19

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 5mg/kg IV on days 1 and 15
Study: NCT05214261

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Safety and efficiency of post operative analgesia between laparoscopic-assisted TAP block and epidural analgesia
Description: Patients in the TAP group will be given a laparoscopic-assisted TAP block with a total of 2mg/kg of 0.25% bupivacaine in the bilateral subcostal region into four spots of the bilateral subcostal region, two on both sides of the lateral abdomen between the anterior iliac spine and lower costal arch. The TAP block is performed after the first trocar placement before the insertion of other trocars and the beginning of the surgical intervention.~In the control group epidural catheters will be placed using landmark- and loss-of-resistance techniques while the patient is on the operating table. Infusions of 4ml/h containing 0.125% levobupivacaine and 5.5 μg/mL fentanyl will be started with a CADD Solis VIP-infusion pump at the time of anesthesia induction.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Safety and efficiency of post operative analgesia between laparoscopic-assisted TAP block and epidural analgesia
Description: Patients in the TAP group will be given a laparoscopic-assisted TAP block with a total of 2mg/kg of 0.25% bupivacaine in the bilateral subcostal region into four spots of the bilateral subcostal region, two on both sides of the lateral abdomen between the anterior iliac spine and lower costal arch. The TAP block is performed after the first trocar placement before the insertion of other trocars and the beginning of the surgical intervention.~In the control group epidural catheters will be placed using landmark- and loss-of-resistance techniques while the patient is on the operating table. Infusions of 4ml/h containing 0.125% levobupivacaine and 5.5 μg/mL fentanyl will be started with a CADD Solis VIP-infusion pump at the time of anesthesia induction.
Study: NCT05163626

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise and cognitive training program
Description: Participants will take part in a combined aerobic exercise and cognitive training program. The program will include moderate cycling exercise and cognitive game resolving at the same time. The tasks will be instructed and supervised by a fitness expert and a trained clinical neuropsychologist.
Study: NCT04738461

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Description: The Posterior Glenohumeral Capsule Stretching Exercise, Pectoral Stretching Exercise, Push-up Against Wall Exercise, Scapular Plan Exercise, 90 Degree Shoulder Flexion Exercise, Isometric External Rotation Exercise and Isometric Internal Rotation Exercise will be applied according to the severity of the disease and the size of the disability.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Physiotherapy
Description: Active-passive exercises accompanied by a physiotherapist and physical therapy methods (electrotherapy and thermotherapy) will be applied in accordance with the standard procedure according to the patient's needs.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise Group
Description: The same exercise program applied to telerehabilitation group.
Study: NCT04727372

Intervention type: OTHER
Intervention: Questionnaire
Description: A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study

Intervention type: OTHER
Intervention: Questionnaire
Description: A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study

Intervention type: OTHER
Intervention: Questionnaire
Description: A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study
Study: NCT06003348

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: OHCit- standard dose
Description: Hydroxycitrate Over-the-counter supplement, not FDA approved or regulated.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Potassium Citrate
Description: 10 mEq Extended-release tablets for oral use

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: OHCit- low dose
Description: Hydroxycitrate Over-the-counter supplement, not FDA approved or regulated.
Study: NCT04980092

Intervention type: OTHER
Intervention: one-year follow-up
Description: patients will be followed during the year after ICU discharge, in order to assess kidney function, and muscle and bone health
Study: NCT05416710

Intervention type: DIAGNOSTIC_TEST
Intervention: Invitae's 84 gene multi-cancer panel.
Description: Invitae's Multi-Cancer panel analyzes 84 genes associated with hereditary cancers across major organ systems.
Study: NCT05939843

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pain Coping Information
Description: A three minute audio recording providing common pain coping techniques (e.g., ice, rest, medication, surgery)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Practice (alone)
Description: A 3-minute audio-guided mindfulness practice.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Introduction + Mindfulness Practice
Description: A 1-minute audio-recorded introduction to the practice of mindfulness followed by a 2-minute audio-guided mindfulness practice

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pain Introduction + Mindfulness Introduction + Mindfulness Practice
Description: A 1-minute audio-recorded introduction to pain, followed by a 1-minute audio-recorded introduction the practice of mindfulness, followed by a 1-minute audio-guided mindfulness practice
Study: NCT06193226

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Description: Cryotherapy can be done in two ways:~1. Open technique: Using cotton swabs or a cryogun spray, the cryogen is delivered directly to the lesion in this technique.~2. Closed technique: Cryo-probes are used to apply the cryogen to the lesion in this procedure.~The spray's nozzle of the Cryogun spray -50 ◦C was situated 1 cm away from the skin's surface and applied on the oral lesion for 30 seconds. Each freezing cycle lasted 10 to 30 seconds, with the subsequent 60-second thaw interval lasting twice as long as the freezing time. The ice ball that formed during freezing was totally melted before the subsequent freezing process could begin.~The application process should went from the core out to the edges. The management of lesions that are too big to be frozen by a single spray requires many overlapping treatments of liquid nitrogen. Mucoceles and erosive lichen planus took 30 to 50 seconds to freeze, whereas fibromas and leukoplakia took 60 to 70 seconds.
Study: NCT03593252

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cefazolin
Description: Intravenous antibiotic to be given on anesthesia induction and prior to incision as a prophylactic antibiotic.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Description: Intravenous antibiotic to be given on anesthesia induction and prior to incision as prophylactic antibiotic.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Metronidazole
Description: Intravenous antibiotic to be given on anesthesia induction and prior to incision as prophylactic antibiotic.
Study: NCT05839158

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HFMT cell suspension
Description: Perform FUE autologous hair transplantation on the patient according to the guidelines and standard procedures. During the procedure, a hollow punch is used to individually punch out follicular units from the donor area. The epidermis, some dermis tissue, sebaceous glands, and surrounding tissue of the follicular units are separated and removed before the remaining follicular tissue is implanted into the recipient area. The separated tissue is trimmed with surgical scissors to create a cell suspension. After completion of the procedure, the HFMT cell suspension is evenly applied to the treatment group surface. Double vaseline gauze is used to cover all donor areas and is then wrapped with sterile dry gauze with moderate pressure.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Mupirocin ointment
Description: the Minoxidil ointment is evenly applied to the control group surface.
Study: NCT03593252

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metronidazole
Description: Intravenous antibiotic to be given on anesthesia induction and prior to incision as prophylactic antibiotic.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nil per os
Description: Fasting orders according to anesthesia prior to surgery: No solid for \>=8 hours, no formula milk/full liquids \>= 4hours; no breast milk or clear fluids \>=2hours.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Nil per os
Description: Fasting orders according to anesthesia prior to surgery: No solid for \>=8 hours, no formula milk/full liquids \>= 4hours; no breast milk or clear fluids \>=2hours.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nil per os
Description: Fasting orders according to anesthesia prior to surgery: No solid for \>=8 hours, no formula milk/full liquids \>= 4hours; no breast milk or clear fluids \>=2hours.
Study: NCT06167811

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: whole-body electrical stimulation
Description: Performed using Miha Bodytec equipment, properly calibrated, with electrodes on the quadriceps, hamstrings, glutes, biceps, triceps, pectorals, abdomen, trapezius, latissimus dorsi and quadratus lumborum muscles.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: whole-body electrical stimulation
Description: Performed using Miha Bodytec equipment, properly calibrated, with electrodes on the quadriceps, hamstrings, glutes, biceps, triceps, pectorals, abdomen, trapezius, latissimus dorsi and quadratus lumborum muscles.
Study: NCT03593252

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clear fluids the day before surgery
Description: As part of bowel preparation, participants will be asked to stick to clear fluids following breakfast the day before surgery. Breast milk is allowed if applicable.
Study: NCT05353504

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Inulin
Description: 28g/day delivered in 2 sachets throughout the day with main meals

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Description: weekly educational sessions to improve individual's eating behaviour

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: equicaloric maltodextrin delivered in 2 sachets throughout the day with main meals
Study: NCT04708249

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: D-chiroinositol
Description: Supplementation with 600 mg of D-chiroinositol, two-times daily on an empty stomach, for 30 days.
Study: NCT06412614

Intervention type: OTHER
Intervention: disease phenotype
Description: evaluation of SSc phenotypes

Intervention type: OTHER
Intervention: disease phenotype
Description: evaluation of SSc phenotypes
Study: NCT06214091

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gastrointestinal decompression
Description: Gastric tube is inserted within 24-hour severe ischemic stroke attack; gastrointestinal decompression is performed for 48 hours.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Gastric tube is inserted within 24-hour severe ischemic stroke attack.
Study: NCT05349006

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azathioprine
Description: Dose related to weigh (100 mg for \<50 kg, 150 mg 50-100 kg, 200 mg for \>100 kg) = 2 to 4 50mg oral caps, daily, during all the study period

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dose related to weigh (100 mg for \<50 kg, 150 mg 50-100 kg, 200 mg for \>100 kg) = 2 to 4 50mg oral caps, daily, during all the study period
Study: NCT05733312

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: InSightec's ExAblate Neuro Model 4000 Type 2.0 (220 KHz) system
Description: Focused ultrasound which targets energy to a specific area in the brain based on imaging and disrupts the blood brain barrier which keeps certain drugs and other molecules out of the brain.
Study: NCT05688722

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Supine position
Description: Patients preoxygenated in supine position before endotracheal intubation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 20 degree head elevation position
Description: Patients preoxygenated in 20 degree head elevation position before endotracheal intubation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 30 degree head elevation position
Description: Patients preoxygenated in 30 degree head elevation position before endotracheal intubation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 45 degree head elevation position
Description: Patients preoxygenated in 45 degree head elevation position before endotracheal intubation
Study: NCT02327455

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stress Dobutamine Echocardiographic using 4DE System
Description: Subjects will undergo their clinically indicated stress dobutamine echocardiographic studies using our standard clinical graded dobutamine stress imaging protcol, employing the iE33 4DE system.
Study: NCT05311592

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERO Dads Program
Description: The HERO Dads Program is a 4-week series of workshops for non-custodial fathers that focuses on improving parenting, offering job support, and financial counseling.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HERO Dads Program
Description: The HERO Dads Program is a 4-week series of workshops for non-custodial fathers that focuses on improving parenting, offering job support, and financial counseling.
Study: NCT06522321

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: i-PRF and FDBA
Description: A mucoperiosteal flap will be raised and atraumatic extraction will be done. An immediate implant with FDBA and I-PRF (experimental group) will be placed according to the standard protocol.~An immediate implant with FDBA( comparative group) will be placed according to the standard protocol .~The surgical wound closure will be coapted with sutures

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: i-PRF and FDBA
Description: A mucoperiosteal flap will be raised and atraumatic extraction will be done. An immediate implant with FDBA and I-PRF (experimental group) will be placed according to the standard protocol.~An immediate implant with FDBA( comparative group) will be placed according to the standard protocol .~The surgical wound closure will be coapted with sutures
Study: NCT04893304

Intervention type: DEVICE
Group type: OTHER
Intervention: co2 laser
Description: types of laser
Study: NCT05620693

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NY-ESO-1 TCR-T
Description: NY-ESO-1 TCR-T treatment